Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients Read more
Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes Read more
Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials Read more
Sobi Receives Approval from Health Canada for Once-Daily Dosing of Orfadin (nitisinone) for the Treatment of HT-1 Read more
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics Read more
Gustave Roussy and Protagen AG collaborate to improve the risk profiling of cancer patients undergoing immunotherapy Read more
SpinalCyte Announces MRI Evidence of Disc Regeneration Following Phase 1/Phase 2 Clinical Trial of CybroCell Dermal Fibroblasts Read more
Aditlys Creates a Natural Tissue-Growing Implant to Treat Patients Suffering from Chronic Kidney Disease Read more